TY - T1的并发症症状有限使用吸入胸腔穿刺术JF -欧洲呼吸杂志》乔和J - 10.1183/13993003.02356 -2019欧元SP - 1902356 AU Sagar Ala Eddin s盟——为玛丽亚·f . AU - Adrianza Andres m . AU -阿尔达纳Grecia l . AU -博罗达·芬奇盟——Armas-Villalba阿里司提戴斯盟——Toquica基督教c . AU -拉尔森,安德鲁J . AU -瓶,玛卡瑞娜r . AU - Grosu Horiana b . AU - Ost, David e . AU - Eapen,乔治·a . AU - Sheshadri Ajay AU - Morice,Rodolfo C. AU - Shannon, Vickie R. AU - Bashoura, Lara AU - Balachandran, Diwakar D. AU - Almeida, Francisco A. AU - Uzbeck, Mateen H. AU - Casal, Roberto F. AU - Faiz, Saadia A. AU - Jimenez, Carlos A. Y1 - 2020/01/01 UR - //www.qdcxjkg.com/content/early/2020/06/01/13993003.02356-2019.abstract N2 -背景:使用抽吸的胸腔穿刺被认为增加了包括气胸和再扩张性肺水肿(REPE)在内的并发症的风险。目前的指南建议将排水量限制在1.5 L以避免REPE。我们的目的是检查有症状的胸腔抽液受限并发症的发生率，并确定REPE的危险因素。方法回顾性队列研究2004年1月1日至2018年8月31日在我院行有症状性吸胸术的成年患者，共10 344例。结果≥1.5 L的胸腔积液在19%的手术中被清除。由于胸部不适(39%)、液体完全排出(37%)和持续咳嗽(13%)而停止开胸。胸片检出率为3.98%，需要介入治疗的仅为0.28%。REPE发生率为0.08%。东部合作肿瘤组表现状态(ECOG)≥3且≥1.5 L时REPE发生率增加(0.04 ~ 0.54%，95% CI 0.13-2.06)。有同侧纵隔移位的患者行胸腔穿胸术没有增加并发症，但移出的液体较少(p<0.01)。结论在症状受限的情况下，即使抽吸量大，也是安全的。 Pneumothorax requiring intervention and REPE are both rare. There were no increased procedural complications in those with ipsilateral mediastinal shift. REPE increased with poor performance status and drainage ≥1.5 L. Symptom limited drainage using suction without pleural manometry is safe.FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. Sagar has nothing to disclose.Conflict of interest: Dr. Landaeta has nothing to disclose.Conflict of interest: M. AdrianzaConflict of interest: Dr. Aldana has nothing to disclose.Conflict of interest: Dr. Pozo has nothing to disclose.Conflict of interest: Dr. Armas Villalba has nothing to disclose.Conflict of interest: Dr. Toquica-Gahona has nothing to disclose.Conflict of interest: Dr. Larson has nothing to disclose.Conflict of interest: Dr. Vial has nothing to disclose.Conflict of interest: Dr. Grosu has nothing to disclose.Conflict of interest: Dr. Ost has nothing to disclose.Conflict of interest: Dr. Eapen has nothing to disclose.Conflict of interest: Dr. Sheshadri has nothing to disclose.Conflict of interest: Dr. Morice has nothing to disclose.Conflict of interest: Dr. Shannon has nothing to disclose.Conflict of interest: Dr. Bashoura has nothing to disclose.Conflict of interest: Dr. Balachandran has nothing to disclose.Conflict of interest: Dr. Almeida has nothing to disclose.Conflict of interest: Dr. Uzbeck has nothing to disclose.Conflict of interest: Dr. Casal has nothing to disclose.Conflict of interest: Dr. Faiz has nothing to disclose.Conflict of interest: Dr. Jimenez has nothing to disclose. ER -